Furthermore, despite increased knowledge of this serious health problem and its consequences, hypertension remains highly prevalent, under-recognized and under-controlled. 3 European Society of Cardiology (ESC) guidelines recommend regular physical activity, with a class IA indication, in order to prevent or delay the onset of hypertension and to reduce cardiovascular risk. Indeed aerobic exercise has been proved to reduce BP by regulating sympathetic activity, arterial stiffness, oxidative stress and by correcting additional components of the metabolic syndrome.
Nonetheless the reported prevalence of systemic hypertension in the athletic population is not as uncommon as expected (3%). 4 High BP represents, in fact, the most common abnormal finding during cardiac screening of athletes and could expose them to an increased risk of cardiovascular events. Therefore, the identification and the management of hypertensive individuals in the setting of pre-participation screening are mandatory.
In this issue of the European Journal of Preventive Cardiology, Niebauer et al. report some brief recommendations for participation in competitive sports of athletes with AH. 5 In athletes, as in the general adult population, hypertension is defined as systolic BP of 140 mmHg or greater and/or diastolic BP of 90 mmHg or greater, repeatedly measured in the office. 6 Children and adolescents have lower BP levels, with normal values of less than 120/80 mmHg. The use of out-of-office BP measurement with 24-hour ambulatory BP monitoring and/ or home BP monitoring is useful to confirm the diagnosis of hypertension, to detect white coat effect and masked hypertension, and monitor BP control.
Pre-participation examination of competitive athletes with AH includes family and personal history, physical examination, cardiovascular risk profile, screening for potential secondary causes of hypertension (i.e. medication or performance enhancing substances such as erythropoietin and anabolic steroids) and 12-lead ECG. Eligibility for participation in competitive athletes with AH is based on the assessment of the cardiovascular risk profile estimated using the European SCORE system, 7 on the presence of target organ damage and/or associated clinical condition ( Figure 1 ).
In patients with low or moderate cardiovascular risk no restriction from competitive sport is required if BP values are normalized. In patients with a high risk or very high risk and adequate control of BP values, participation in all competitive sports is allowed, with the exclusion of power disciplines. Except in the presence of very high BP values (grade 3 hypertension), athletes with treated or untreated hypertension should not be exempted from regular exercise, especially aerobic exercise, which is considered beneficial as part of lifestyle changes to reduce BP. In all circumstances, if BP values are not well controlled, temporary restriction from competitive sport is recommended.
Routinely, as a part of the medical programme, exercise testing is performed to assess cardiovascular adaptations during effort and exercise-induced arrhythmias. As a small percentage of athletes during exercise exceed upper BP limit values, without organ damage, it is not clear if these patients should be discouraged from regular sports activities. Moreover, it is questionable if an abnormal BP response to exercise in highly trained athletes represents an adaptation to elevated exercise performance or the initial impairment of vascular relaxation with potential clinical implications. Step-wise approach to management of competitive athletes with arterial hypertension. ACC: associated clinical condition; CV: cardiovascular; LV: left ventricular; RF risk factor; TOD: target of damage.
diagnostic and prognostic applications are controversial. As expected, during effort, physiologically systolic BP increases, whereas the diastolic BP shows only minimal change. The upper reference values are 220 mmHg in male and 200 mmHg in female athletes for systolic BP, and 85 mmHg and 80 mmHg, respectively, for diastolic BP. 8 BP values obtained during exercise should not be used for a definitive diagnosis of hypertension. However, this element could be a marker of underlying hypertension. Caselli et al. 9 in a recent study show how an exaggerated BP response to exercise increases the risk for incident hypertension (HR 3.6) in highly trained and normotensive young athletes over a middle-term period. These results are in line with data derived from the general population, in the middle age range. Finally, a study by Miyai et al. 10 shows how patients with high resting BP, together with an exaggerated increase of BP during exercise, have an increased risk of future hypertension by 2.3 times. Therefore, patients with high normal BP at rest should be carefully evaluated by clinicians and stratified after exercise testing.
The authors have further emphasized the importance of the early signs of cardiac target organ damage in hypertensive athletes. In this setting, a good assessment and correct interpretation of pathological left ventricular hypertrophy (LVH), often an expression of systemic hypertension, still represents a major clinical challenge. In fact, LVH in athletes could be an expression of physiological adaptation to intense and chronic exercise, so called 'athlete's heart', but also an expression of further pathological conditions such as hypertrophic cardiomyopathy, which is reported as the first cause of sudden cardiac death (SCD) in athletes less than 35 years of age. 11 In patients with an underlying substrate of cardiomyopathies, intense exercise could indeed represent a trigger for malignant arrhythmias and consequently increase the risk of SCD. Due to clinical overlapping phenotypes, the differential diagnosis between the adaptive and maladaptive response to exercise is not easy but is crucial. Knowledge of the underlying physiological mechanism related to different sports activities could support physicians in a first evaluation of LVH. Sports with static or isometric loads lead to concentric LVH (caused by an increase in total vascular resistance), with a potential risk of the development of AH. Dynamic sports with intensive aerobic activity could cause an increase of the left ventricular cavity, with proportional thickening of the walls, more likely leading to eccentric hypertrophy. These patterns of biventricular remodelling may also be different in relation to the intensity and the duration of exercise performed, as well as to age, sex and ethnicity. Furthermore, athlete's heart is not associated with diastolic dysfunction and its morphological changes are reversible by detraining. On the other hand, hypertensive heart is predominantly characterized by the presence of concentric hypertrophy, which is the result of functional and structural changes that are deleterious in the long term, leading to diastolic and/or systolic dysfunction, eccentric hypertrophy and, finally, to heart failure. Paradoxically, in the literature some studies have established that physical activity is associated with regression or prevention of LVH, suggesting a beneficial effect of exercise.
As reported by De Innocentiis et al. in a recent review, 12 several diagnostic tools (resting ECG, echocardiography, cardiovascular magnetic resonance) and methods (two and three-dimensional measurements, myocardial strain imaging, etc.) involved in the preparticipation examination of athletes allow the comprehensive morphological and functional evaluation of the heart and distinction between physiological and pathological adaptation. However, their utility in clinical practice is still limited by the lack of validated clinical cut-offs stratified by age, gender, body size, ethnicity and type of discipline.
Nevertheless, studies have demonstrated that, independently of LVH, increased pulse pressure is a potent predictor of cardiovascular events, especially in older age. 13 In the management of patients with AH, this functional marker of target organ damage should probably be considered, in order to improve the diagnosis and treatment of hypertension, particularly in individuals with an elevated cardiovascular risk such as master athletes.
In conclusion, AH represents the most relevant risk factor for cardiovascular disease also in an apparently healthy population such as athletes. Its early recognition is mandatory to avoid fatal major events. While eligibility for competitive sports should be restricted if target organ damage is present, hypertensive athletes should not be discouraged from physical activity, especially aerobic exercise, because of its multiple advantages in maintaining and improving cardiovascular health.
In the presence of AH and LVH, physicians should likewise contemplate the potential presence of an underlying substrate that could lead to an increased risk of fatal arrhythmias and SCD triggered by intensive exercise. The detection of a cardiomyopathy has, in fact, significant clinical and prognostic implications regarding competitive sports participation. In this setting, it is reasonable to find a balance between possible adverse events and the multiple advantages, including psychological benefits, related to sports activities, with more regard to young individuals.
Further research would be needed to define the correct level of sports also in this athlete population, in order to allow the proper discipline for the proper athlete.
